Co-Author
This page shows the publications co-authored by Sharmila Dorbala and Ron Blankstein.
Connection Strength
6.788
-
Adding calcium scoring to myocardial perfusion imaging: Does it alter physicians' therapeutic decision making? J Nucl Cardiol. 2010 Apr; 17(2):168-71.
Score: 0.433
-
A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. J Am Coll Cardiol. 2021 09 28; 78(13):1385-1389.
Score: 0.240
-
Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022 Apr; 29(2):440-446.
Score: 0.223
-
Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 05 10; 62(5):716-722.
Score: 0.223
-
Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease. J Nucl Cardiol. 2021 08; 28(4):1395-1408.
Score: 0.207
-
Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019 Jun; 1(2):e180018.
Score: 0.205
-
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
Score: 0.201
-
Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
Score: 0.199
-
Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
Score: 0.193
-
Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
Score: 0.185
-
Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 10; 24(5):1741-1758.
Score: 0.182
-
Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
Score: 0.169
-
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017 02; 24(1):86-99.
Score: 0.166
-
Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46.
Score: 0.154
-
Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9.
Score: 0.153
-
Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. J Am Coll Cardiol. 2014 Aug 12; 64(6):631.
Score: 0.147
-
Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
Score: 0.144
-
Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. J Am Coll Cardiol. 2014 Jun 17; 63(23):2590.
Score: 0.143
-
Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
Score: 0.141
-
Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
Score: 0.140
-
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
Score: 0.138
-
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
Score: 0.137
-
Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013 Apr; 20(2):310-2.
Score: 0.133
-
Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging. J Nucl Cardiol. 2012 Aug; 19(4):814-7.
Score: 0.127
-
Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9.
Score: 0.126
-
Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8.
Score: 0.125
-
Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
Score: 0.108
-
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study. JAMA Cardiol. 2022 01 01; 7(1):93-99.
Score: 0.061
-
Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer. J Nucl Cardiol. 2021 Nov 24.
Score: 0.061
-
Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J. 2021 Sep 07.
Score: 0.060
-
Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging. 2022 02; 15(2):312-321.
Score: 0.060
-
Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus. J Am Heart Assoc. 2021 07 06; 10(13):e018555.
Score: 0.059
-
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World. JACC Cardiovasc Imaging. 2021 09; 14(9):1787-1799.
Score: 0.059
-
Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 11; 14(11):2212-2220.
Score: 0.058
-
Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
Score: 0.057
-
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. JACC Cardiovasc Imaging. 2020 08; 13(8):1815-1833.
Score: 0.055
-
Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2021 12; 28(6):2976-2987.
Score: 0.055
-
Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
Score: 0.055
-
Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022 Feb; 29(1):37-42.
Score: 0.055
-
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. J Am Coll Cardiol. 2020 06 30; 75(25):3177-3183.
Score: 0.055
-
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. Ann Thorac Surg. 2020 08; 110(2):733-740.
Score: 0.055
-
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. Can J Cardiol. 2020 07; 36(7):971-976.
Score: 0.055
-
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
Score: 0.053
-
Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2021 10; 28(5):1988-1997.
Score: 0.053
-
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2021 06; 28(3):1089-1099.
Score: 0.051
-
Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
Score: 0.051
-
Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
Score: 0.051
-
Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
Score: 0.048
-
Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
Score: 0.048
-
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
Score: 0.047
-
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol. 2018 Feb; 25(1):298-319.
Score: 0.047
-
Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
Score: 0.047
-
Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
Score: 0.046
-
Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
Score: 0.046
-
Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
Score: 0.045
-
Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 08; 58(8):1341-1353.
Score: 0.045
-
Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
Score: 0.044
-
Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
Score: 0.043
-
Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
Score: 0.040
-
Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
Score: 0.038
-
Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
Score: 0.038
-
Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
Score: 0.037
-
Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
Score: 0.037
-
Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
Score: 0.036
-
Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
Score: 0.035
-
Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013 May 21; 61(20):2098-106.
Score: 0.033
-
Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34.
Score: 0.032
-
Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012 Oct 09; 126(15):1858-68.
Score: 0.032
-
Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011 Oct 18; 58(17):1807-16.
Score: 0.030
-
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011 Nov 15; 124(20):2215-24.
Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.